Key factors in the acquisition of contrast kinetic data for oncology

Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) has recently emerged as a promising method for both diagnosis and prognosis of cancer despite considerable variation in both the methods of data acquisition and analysis. Both to facilitate integration of results from multiple institutions and to ensure that the data reflect the underlying physiology as accurately as possible, several aspects of data acquisition should be taken into account when developing protocols for DCE‐MRI regardless of how the data are analyzed. Among the relevant issues are the relationship between signal enhancement and contrast agent concentration, intra‐ or inter‐patient variation in the blood contrast agent concentration as a function of time, requirements for spatial and temporal resolution, the impact of tumor heterogeneity, and the impact of patient motion during the study. This review considers these factors and, when possible, makes specific recommendations for addressing them experimentally. J. Magn. Reson. Imaging 1999;10:254–259. © 1999 Wiley‐Liss, Inc.

[1]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[2]  J. Evelhoch,et al.  Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. comparison with microspheres in tumors , 1999, Magnetic resonance in medicine.

[3]  J L Evelhoch,et al.  Deuterium NMR tissue perfusion measurements using the tracer uptake approach: I. optimization of methods , 1999, Magnetic resonance in medicine.

[4]  M A Helvie,et al.  Linear motion correction in three dimensions applied to dynamic gadolinium enhanced breast imaging. , 1999, Medical physics.

[5]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[6]  S G Orel,et al.  Differentiating benign from malignant enhancing lesions identified at MR imaging of the breast: are time-signal intensity curves an accurate predictor? , 1999, Radiology.

[7]  L. Esserman,et al.  Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Gomori,et al.  Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging--pilot study. , 1999, Radiology.

[9]  J C Ehrhardt,et al.  Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging. , 2000, AJR. American journal of roentgenology.

[10]  G. Glover,et al.  Breast disease: dynamic spiral MR imaging. , 1998, Radiology.

[11]  B K Rutt,et al.  Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.

[12]  H. Degani,et al.  Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  M V Knopp,et al.  Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  J. Witjes,et al.  Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. , 1998, Radiology.

[15]  J. Barentsz,et al.  Fast dynamic contrast enhanced MR imaging of cervical carcinoma. , 1998, Clinical radiology.

[16]  D B Kopans,et al.  Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. , 1997, Radiology.

[17]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[18]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.

[19]  M D Schnall,et al.  Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. , 1997, AJR. American journal of roentgenology.

[20]  R M Weisskoff,et al.  Water diffusion and exchange as they influence contrast enhancement , 1997, Journal of magnetic resonance imaging : JMRI.

[21]  F S Prato,et al.  A novel fast T1‐mapping method , 1994, Journal of magnetic resonance imaging : JMRI.

[22]  M Recht,et al.  Method for the quantitative assessment of contrast agent uptake in dynamic contrast‐enhanced MRI , 1994, Magnetic resonance in medicine.

[23]  J. Evelhoch.  Tracer Measurements of Blood Flow , 1994 .

[24]  M. Leach,et al.  A rapid interleaved method for measuring signal intensity curves in both blood and tissue during contrast agent administration , 1993, Magnetic resonance in medicine.

[25]  N J Pelc,et al.  Optimization of flip angle for T1dependent contrast in MRI , 1993, Magnetic resonance in medicine.

[26]  R. Paola,et al.  Factor Analysis of Dynamic Magnetic Resonance Imaging in Predicting the Response of Osteosarcoma to Chemotherapy , 1992, Investigative radiology.

[27]  P. Gowland,et al.  Fast and accurate measurements of T1 using a multi‐readout single inversion‐recovery sequence , 1992, Magnetic resonance in medicine.

[28]  J L Evelhoch,et al.  Measurement of relative regional tumor blood flow in mice by deuterium NMR imaging , 1992, Magnetic resonance in medicine.

[29]  R. Henkelman,et al.  Practical Implementation and Optimization of One‐shot T1 imaging , 1991, Magnetic resonance in medicine.

[30]  H. W. Korin,et al.  Adaptive technique for three-dimensional MR imaging of moving structures. , 1990, Radiology.

[31]  A. Michalowski,et al.  The relationship between regional variations in blood flow and histology in a transplanted rat fibrosarcoma. , 1990, British Journal of Cancer.

[32]  M. Raichle,et al.  Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  M Intaglietta,et al.  Tissue perfusion inhomogeneity during early tumor growth in rats. , 1979, Journal of the National Cancer Institute.

[34]  R. R. Ernst,et al.  Application of Fourier Transform Spectroscopy to Magnetic Resonance , 1966 .

[35]  S. Kety,et al.  THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES. , 1948, The Journal of clinical investigation.

[36]  E. Quimby,et al.  The Use of Radioactive Sodium as a Tracer in the Study of Peripheral Vascular Disease1 , 1945 .